Conversely, in primary follicular thyroid carcinomas, RAS variants and PAX8/Peroxisome Proliferator-Activated receptor γ (PPARγ) fusions are found in approximately 80% of cases [26]. Here, PAX8 is linked to thyroid gland follicular carcinoma.